Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC2007 Er-thermo-yellow
The First Fluorescent Probe for Targeted Visualization of Temperature at the Endoplasmic Reticulum #222222; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.17px; text-align: start; text-in
More description
DCC2006 Erthermac
Novel thermosensitive fluorescent dye, visualizing thermogenesis in stimulated single-cell brown adipocytes
More description
DCC2005 Ertapenem Disodium
Carbapenem antibiotic, inhibiting cross-linking of the peptidoglycan layer of bacterial cell walls by blocking penicillin-binding proteins (PBPs)
More description
DCC2004 Erß Nir Probe P5
The first ERβ-targeted near-infrared (NIR) inherently fluorescent probe, showing the advantages of high ERβ selectivity, good optical properties, and excellent ERβ imaging capability in living cells
More description
DCC2003 Erso-dfp
Novel Activator of the Anticipatory Unfolded Protein Response with Enhanced Selectivity for Estrogen Receptor Positive Breast Cancer
More description
DCC2002 Errα Degrader-1
Novel PROTAC Estrogen-related Receptor α (ERRα) Degrader
More description
DCC2001 Erk-cliptac
Novel degrader of ERK1/2, eliciting downregulation of phospho-ERK1/2 signal.
More description
DCC2000 Erk Inhibitor Ii, Negative Control
Negative control for ERK Inhibitor II AOB6420
More description
DCC1999 Eritoran
Analogue of the lipid A portion of the endotoxin lipopolysaccharide (LPS) with potential immunomodulating activity, binding to the Toll-like receptor (TLR)/CD14/MD2 receptor complex, inhibiting the activation of the receptor complex by LPS
More description
DCC1998 Erioflorin
Novel ATP-competitive Selective c-Jun N-terminal kinase (JNK) inhibitor
More description
DCC1997 Ergotamine
Natural Nsp15 inhibitor against SARS-COV2
More description
DCC1996 Ercc1-xpf-in-4
Novel potent inhibitor of ERCC1-XPF activity, targeting DNA repair in tumor cells
More description
DCC1995 Erbb-in-1
Novel ErbB type I receptor tyrosine kinase inhibitor for the treatment of hyperproliferative diseases
More description
DCC1994 Erap1-in-2
Novel competitive inhibitor of ERAP1 aminopeptidase activity
More description
DCC1993 Erap1 -in-1
Novel Selective ERAP1 Inhibitor
More description
DCC1992 Er-38925
Retinoic acid receptor (RAR) subtype α-selective agonist
More description
DCC1991 Er-119884
Selective squalene synthase (SQS) inhibitor
More description
DCC1990 Er Degrader 40
Novel Oral Selective Estrogen Receptor Degrader with Highly Improved Antitumor Effect and Favorable Druggability
More description
DCC1989 Epz033294
Novel SMYD2 inhibitor
More description
DCC1988 Epz032597
Novel selective SMYD2 inhibitor
More description
DCC1986 Epz005687n
Inactive isomer of EPZ005687 and can be used as the negative control for EPZ005687
More description
DCC1985 Eptapirone Fumarate
Potent, selective, high efficacy 5-HT1A receptor agonist
More description
DCC1984 Eps-in-1
Novel inhibitor of extracellular polymeric substances (EPS)
More description
DCC1983 Eprazinone
Mucolytic and bronchospasm relieving agent
More description
DCC1982 Epi-nocardicin G
The precursor of the nocardicins
More description
DCC1981 Epinastine Hydrobromide
Second-generation antihistamine and mast cell stabilizer, being highly selective for the H1 receptor
More description
DCC1980 Epibestatin Hydrochloride
Novel stabilizer of 14-3-3 PPIs, Diastereoepimer of aminopeptidase inhibitor bestatin
More description
DCC1979 Epi-0023
Novel selrctive SETD8 inhibitor without inhibiting G9a, SETD7, RmtA, and PRMT1
More description
DCC1978 Ephb3-in-9
The first potent and specific inhibitor of a single Eph isoform EphB3
More description
DCC1977 Ephb3-in-10
Novel clickable potent and specific inhibitor of EphB3
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X